Gastroenterology billing carries more coding risk than most specialties because a single colonoscopy can shift categories mid-procedure — screening becomes diagnostic the moment a polyp gets removed.
Getting that transition wrong, or misreading a CPT code description, is where most GI reimbursement problems start. CMS and commercial payers apply different rules to the same procedure depending on why it was performed, and the coding must reflect intent and findings, not just the scope insertion.
In this guide, we’ll go through the specifics of gastroenterology billing and coding.
- The screening, surveillance, diagnostic, and therapeutic classification system
- Correct GI CPT code descriptions for colonoscopy and EGD procedures
- Documentation requirements that tie findings to the billed code
- Prior authorization rules for advanced endoscopic procedures
- Common denial causes and the coding-stage fixes that prevent them
- Modifier PT and why it’s one of the highest-value modifier rules in GI billing
TLDR: Gastroenterology billing
- Accurate GI billing depends on correctly classifying colonoscopies as screening, surveillance, diagnostic, or therapeutic
- Each classification affects patient cost-sharing and modifier requirements
- Modifier PT preserves preventive cost-sharing when a screening colonoscopy converts to therapeutic
- CPT codes for EGD and colonoscopy are frequently misdescribed in billing content — verify against current AMA CPT
- Modifiers 33, PT, 59, and 25 are the most common denial triggers when misapplied
- Prior authorization is generally not required for routine endoscopy under traditional Medicare but varies widely across commercial payers
Which GI CPT codes are billed most often?
Several widely circulated GI billing guides mix up code descriptions, and using the wrong one creates a documentation mismatch that invites denial or audit. The table below uses descriptions verified against the current AMA CPT set.
Colonoscopy codes
| CPT code | Description |
| 45378 | Diagnostic colonoscopy |
| 45380 | Colonoscopy with biopsy |
| 45385 | Colonoscopy with removal of polyp(s) by snare technique |
| 45390 | Colonoscopy with endoscopic mucosal resection (EMR) |
| 45391 | Colonoscopy with endoscopic ultrasound examination |
EGD codes
| CPT code | Description |
| 43235 | Diagnostic EGD, without biopsy |
| 43239 | EGD with biopsy, single or multiple |
| 43249 | EGD with balloon dilation of the esophagus (<30mm) |
| 43253 | EGD with EUS-guided fine needle aspiration/biopsy |
Confirm any code your practice hasn’t billed recently against the current AMA CPT Professional Edition before submission — annual updates can shift descriptions and bundling rules.
How do you classify colonoscopies correctly?
The same colonoscope insertion can end up billed four different ways depending on intent and findings, and mixing these up changes what the patient owes as much as what the payer pays.
Screening
Preventive exam with no symptoms or prior findings. The patient is asymptomatic and meets age or risk-based criteria for colorectal cancer screening. Under the ACA, screening colonoscopies for eligible patients carry no patient cost-sharing.
Surveillance
Follow-up exam for a patient with prior polyps or high-risk history. The patient had findings on a previous exam that indicate increased risk. Surveillance has a different recommended interval than initial screening.
Diagnostic
Ordered to evaluate symptoms — rectal bleeding, unexplained anemia, abnormal imaging, change in bowel habits. The clinical indication drives the diagnostic classification, not the findings.
Therapeutic
An intervention is performed during the procedure — polypectomy, biopsy, hemostasis, dilation. A screening colonoscopy that finds and removes a polyp converts from screening to therapeutic during the procedure.
In practice, the conversion from screening to therapeutic is the highest-value classification rule in GI billing — and where Modifier PT applies.
What does Modifier PT do and why does it affect GI revenue?
Modifier PT is required when a screening colonoscopy converts to a therapeutic procedure. Without it, the claim shifts to standard cost-sharing, which can result in unexpected patient bills and payer processing errors.
How it works
- The procedure is now therapeutic, not screening
- A patient comes in for a routine screening colonoscopy
- During the procedure, the physician finds and removes a polyp
- Without PT, the patient may be billed a deductible and coinsurance they shouldn’t owe
- Modifier PT preserves the patient’s preventive-service cost-sharing protection under Medicare
Why it gets missed
Many billing teams apply the therapeutic CPT code (45385 for snare polypectomy) without adding Modifier PT. The code is correct, but without the modifier, the payer’s system treats it as a non-screening therapeutic procedure and applies standard cost-sharing.
For the patient, that’s an unexpected bill. For the practice, that’s a patient complaint and potential reprocessing.
Missing Modifier PT is one of the most common GI billing errors — and one of the most financially consequential for patients, which makes it a compliance and patient-relations issue alongside the coding question.
Which modifiers move GI reimbursement?
A handful of modifiers show up constantly in GI claims. The infographic below covers the four that carry the most financial weight.
Modifier 33
Identifies a preventive service under ACA guidelines. For screening colonoscopies in eligible patients, Modifier 33 communicates that no patient cost-sharing applies. Used primarily by commercial payers (Medicare uses specific G-codes or Modifier PT for screening conversion).
Modifier 59 / XS
Indicates a distinct procedural service when NCCI edits would otherwise bundle two procedures together. In GI billing, this applies when separate procedures are performed at different anatomical sites during the same session. Documentation must support the distinctness.
Modifier 25
Required when billing a significant, separately identifiable E/M visit on the same day as a GI procedure. The E/M must document a clinical encounter that stands independently from the procedure indication.
When is prior authorization required for GI procedures?
PA requirements vary widely by payer and procedure, and treating all GI services the same way wastes staff time on codes that don’t need authorization while missing the ones that do.
Traditional Medicare
Generally doesn’t require PA for most routine endoscopic procedures (diagnostic colonoscopy, screening colonoscopy, routine EGD).
Commercial payers
Frequently require PA for advanced or high-cost procedures.
- Capsule endoscopy
- Endoscopic ultrasound (EUS)
- Advanced therapeutic endoscopy (EMR, stent placement)
- ERCP (endoscopic retrograde cholangiopancreatography)
Practical approach
Confirm PA requirements per payer and per procedure before scheduling rather than applying a blanket rule. Many practices maintain a payer-specific PA matrix that maps CPT codes to authorization requirements by insurer.
What documentation supports GI reimbursement?
CMS requires documentation that ties the billed code directly to what was found and done — not just that a procedure occurred. For GI procedures, the endoscopy report is the primary documentation source.
Required elements
- Pathology handling instructions
- Number and location of specimens collected
- Follow-up recommendations tied to the findings
- Findings, including location and size of any lesions
- Interventions performed (biopsy, polypectomy, dilation, hemostasis)
- Indication for the procedure (symptoms, screening criteria, surveillance history)
Screening-to-therapeutic documentation
When a screening colonoscopy converts to therapeutic, the endoscopy report should document the original screening indication and the finding that triggered the intervention. A report that says “colonoscopy with polypectomy” without noting the screening indication gives the coder no basis to apply Modifier PT.
What causes most GI claim denials?
A recurring set of issues accounts for most gastroenterology denials, and nearly all are preventable at the coding or documentation stage.
- Incomplete documentation of findings or specimens
- Diagnosis code not clearly supporting medical necessity
- Missing prior authorization on advanced procedures (EUS, ERCP, capsule endoscopy)
- Wrong CPT code applied when a procedure description was misread from a reference table
- Missing Modifier PT on screening-to-therapeutic conversions
- NCCI bundling edits not reviewed before submission
For most GI practices, the Modifier PT error is the single highest-revenue-impact denial because it affects every screening colonoscopy that finds a polyp — which is a significant percentage of screening volume.
How do ICD-10 codes support GI claims?
Diagnosis coding for GI procedures requires specificity about both the clinical indication and the findings.
| ICD-10-CM | Description |
| Z12.11 | Encounter for screening for malignant neoplasm of colon |
| Z86.010 | Personal history of colonic polyps |
| K63.5 | Polyp of colon |
| K57.30 | Diverticulosis of large intestine without perforation or abscess |
| K21.0 | Gastro-esophageal reflux disease with esophagitis |
| K25.9 | Gastric ulcer, unspecified |
| R19.5 | Other fecal abnormalities (positive fecal occult blood) |
The diagnosis on the claim must match the endoscopy report’s findings. A screening colonoscopy uses Z12.11. A surveillance colonoscopy for prior polyp history uses Z86.010. A diagnostic colonoscopy for rectal bleeding uses the symptom code. Mismatching the diagnosis to the classification is a medical necessity denial.
Your GI claims shouldn’t lose revenue on a missing modifier
Gastroenterology reimbursement depends on getting three things right together — the correct CPT code for what was done, the modifier that reflects why it was done, and documentation that ties the two together. Practices that treat these as three separate afterthoughts are the ones losing revenue to preventable denials.
MedHeave builds gastroenterology-specific billing controls around procedure-level detail, whether your practice is a single-location GI group or a multi-site endoscopy center.
- Screening-to-therapeutic conversion tracking with Modifier PT applied correctly
- CPT and modifier review against current AMA guidance before submission
- Prior authorization management for EUS, ERCP, and capsule endoscopy
- Performance-based pricing (4-7% of collections) with no lock-in
- Denial tracking specific to GI coding and NCCI edits
Contact us if GI denials are cutting into your collections and your coding workflow needs a review.
Related guides & resources
The resources below cover closely related topics and the broader service workflow they connect to:
- Gastroenterology billing services — Gastroenterology billing services
- Endoscopy CPT codes — Endoscopy CPT Codes: EGD, Colonoscopy & Billing (2026)
- CPT code for colonoscopy — CPT Code for Colonoscopy: 45378, 45385, Medicare & Modifiers
- Medical billing — Beginner’s Guide to Medical Billing and Coding
- Medical coding — Medical Coding 101: The Ultimate Guide
Frequently asked questions
Here are some commonly asked questions on this topic:
Screening colonoscopies are preventive exams for asymptomatic patients meeting age or risk criteria — they carry no patient cost-sharing under ACA rules. Diagnostic colonoscopies are ordered to evaluate specific symptoms like rectal bleeding or unexplained anemia. When a screening exam finds and removes a polyp, it converts to therapeutic and requires Modifier PT under Medicare to preserve the patient’s preventive cost-sharing protection. The classification depends on the clinical indication and findings, not just the procedure itself.
CPT 43235 describes a diagnostic esophagogastroduodenoscopy (EGD) without biopsy. EGD with biopsy is billed separately as CPT 43239. EGD with balloon dilation uses 43249, and EGD with EUS-guided FNA/biopsy uses 43253. Each code describes a different level of intervention, and selecting the wrong one creates a documentation mismatch that triggers payer review. Verify any code your practice hasn’t billed recently against the current AMA CPT Professional Edition.
No. Traditional Medicare generally doesn’t require prior authorization for most routine endoscopic procedures. Commercial payers frequently require PA for advanced or high-cost procedures including endoscopic ultrasound (EUS), ERCP, capsule endoscopy, and advanced therapeutic endoscopy. Requirements vary by payer and by specific plan — confirm per procedure and per insurer before scheduling rather than applying a blanket assumption.
Modifier PT identifies a screening colonoscopy that became diagnostic or therapeutic during the procedure (typically when a polyp is found and removed). Under Medicare, it preserves the patient’s preventive-service cost-sharing protection. Without it, the claim is processed as a standard therapeutic procedure, and the patient may be billed a deductible and coinsurance they shouldn’t owe. Missing Modifier PT is one of the most common GI billing errors.
The most frequent denial triggers are missing Modifier PT on screening-to-therapeutic conversions, insufficient medical necessity documentation in the endoscopy report, unreviewed NCCI bundling edits before submission, missing prior authorization on advanced procedures, and incomplete documentation of lesion findings or specimen handling. Most of these are preventable at the coding or documentation stage before the claim is submitted.
